CollPlant Biotechnologies (CLGN) Total Current Liabilities (2018 - 2025)

CollPlant Biotechnologies' Total Current Liabilities history spans 8 years, with the latest figure at $2.7 million for Q4 2025.

  • For Q4 2025, Total Current Liabilities fell 10.03% year-over-year to $2.7 million; the TTM value through Dec 2025 reached $2.7 million, down 10.03%, while the annual FY2025 figure was $2.7 million, 10.03% down from the prior year.
  • Total Current Liabilities reached $2.7 million in Q4 2025 per CLGN's latest filing, down from $3.0 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $3.3 million in Q4 2023 to a low of $2.7 million in Q4 2025.
  • Average Total Current Liabilities over 5 years is $3.0 million, with a median of $3.0 million recorded in 2021.
  • Peak YoY movement for Total Current Liabilities: decreased 11.04% in 2021, then rose 4.7% in 2023.
  • A 5-year view of Total Current Liabilities shows it stood at $3.0 million in 2021, then rose by 3.02% to $3.1 million in 2022, then increased by 4.7% to $3.3 million in 2023, then decreased by 8.64% to $3.0 million in 2024, then decreased by 10.03% to $2.7 million in 2025.
  • Per Business Quant, the three most recent readings for CLGN's Total Current Liabilities are $2.7 million (Q4 2025), $3.0 million (Q4 2024), and $3.3 million (Q4 2023).